Schindler Ae
No ORCID on file
· 61 papers in corpus
· active 1989-2019
Study types
- article 44
- other 10
- review 4
- case-report 1
- editorial 1
Condition tags
- endometriosis 52
- infertility 10
- dysmenorrhea 6
- dyspareunia 5
- die_deep_infiltrating 5
- adenomyosis 5
- chronic_pelvic_pain 2
- thoracic_endometriosis 1
- endometrioma 1
Top journals
Frequent coauthors
article
2019
Background Severe forms of adenomyosis are a serious gynecological problem. In most cases, conservative treatment of this pathology is unsuccessful. Adenomyomectomy by Osada's approach seems to be the most promising solution. The present st…
article
2018
Endometriosis is among the prevalent gynecological diseases and diagnosed in 10% of women of reproductive age. Endometriosis/adenomyosis is becoming increasingly a health-social problem, which is associated with severe clinical manifestatio…
review
2017
// Pedro-Antonio Regidor 1 and Adolf E. Schindler 2 1 Exeltis West Europe & Germany, Ismaning, Germany 2 Institut für Medizinische Forschung, Essen, Germany Correspondence to: Pedro-Antonio Regidor, email: // Keywords : dienogest, drospiren…
2016
The use of 2 × 2000 mg myoinositol + 2 × 200 μg folic acid per day is a safe and promising tool in the effective improvement of symptoms and infertility for patients with a polycystic ovary syndrome (PCOS). Using a questionnaire an observat…
article
2013
The idea of quality improvement in the management of endometriosis has been brought to attention throughout Europe. This - first and foremost - includes the implementation of centers specialized in treating endometriosis. This leads to qual…
other
2013
It is becoming evident that oral hormonal contraceptives-besides being well established contraceptives-seem to become important medications for many functional or organic disturbances. So far, clinical effectiveness has been shown for treat…
article
2011
Adolf E SchindlerInstitute for Medical Research and Education, Essen, GermanyAbstract: Endometriosis is a chronic disease primarily affecting women of childbearing age, in which endometriotic lesions form outside the uterus, typically leadi…
article
2011
Endometriosis is a chronic disease primarily affecting women of childbearing age, in which endometriotic lesions form outside the uterus, typically leading to painful symptoms, fatigue, and infertility. The symptoms of endometriosis may cau…
other
2010
PURPOSE: Hormonal treatment of endometriosis is often continued for long periods and has the potential to affect many essential metabolic processes. The current study aimed to determine the effects and safety of high-dose dienogest as a med…
editorial
2010
Over the past 50 years hormonal contraceptives have gradually developed to be cost-effective medical treatment modalities for primary and secondary therapy of endometriosis/adenomyosis. This is particularly true for the various estrogen/pro…
article
2010
Besides the contraceptive effect of the various hormonal contraceptives, it is intended to demonstrate the non-contraceptive health benefits for treatment and prevention of bleeding problems, menstruation-related pain and other disorders, s…
article
2009
In a clinical pilot study, 21 women with endometriosis have been primarely treated with dienogest 2 x 10 mg daily p.o. for 24 weeks. Besides the effect on endometriosis the action of such high-dose progestogen treatment on the breast was ev…
article
2009
article
2009
other
2009
article
2008
In Europa wird die Idee der Qualitätsverbesserung auf dem Gebiet der Endometriose vertieft. Verschiedene "Task Forces" arbeiten mit zum Teil identischen Methoden am gleichen Ziel. Die Bildung spezialisierter Endometriosezentren verbunden mi…
other
2008
article
2008
Endometriose ist eine der häufigsten gutartigen, proliferativen Erkrankungen der Frau. Die Therapie konzentriert sich auf drei Problemkreise: 1. Schmerzen (vor allem zyklusabhängige Beschwerden, aber auch zyklusunabhängige Beschwerden, Blas…
article
2007
Endometriose ist eine häufige sogenannte "gutartige proliferative Erkrankung" der Frau (ähnlich wie Myom, Endometriumhyperplasie und Mastopathie). Zur Erklärung der Entstehung sind verschiedene Endometriosetheorien entwickelt worden. Es bes…
article
2006
High-dose dienogest (20 mg/day) was used for the treatment of endometriosis in women aged 18-52 years after laparoscopic and histological diagnosis of endometriosis and staging according to the revised American Fertility Society criteria. T…
article
2006
Gonadotropin-releasing hormone (GnRH) agonists have gained extensive clinical use, ranging from reproduction to oncology. There are many clinically available GnRH agonists and these can be used via various methods of delivery, ranging from …
review
2005
The ENZIAN-Score is presented as a new instrument to classify the deep infiltrating endometriosis. Especially the retroperitoneal part of the severe endometriosis is focussed on. In analogy to an oncological staging four different stages ar…
article
2004
ObjectiveThe present study aims at demonstrating the equivalence of the 28-day and 3-month formulations of triptorelin SR (sustained release) in terms of percentage of patients achieving castration levels of estradiol (<==50 pg/mL) 84 days …
review
2004
Adhesion formation is of major concern to the pelvic surgeon. Most patients develop postoperative adhesions regardless of whether the mode of access to the abdominal cavity is by laparoscopy or laparotomy. Infertility is related to adhesion…
article
2004
Endometriosis is generally a benign condition. However, there is a tendency towards progression and in part deep infiltrating processes occur, which can lead to obstruction and even silent loss of organ function such as kidney failure. Here…